Human Papilloma Virus Genotypes and Induced Protein-10 as Predictors for the Clinical Response to Candida Antigen Immunotherapy of Warts | ||||
| Egyptian Journal of Medical Microbiology | ||||
| Volume 28, Issue 2, April 2019, Page 129-135 PDF (577.4 K) | ||||
| Document Type: New and original researches in the field of Microbiology. | ||||
| DOI: 10.21608/ejmm.2019.282756 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Ahmed A. Shaheen; Shymaa A. Mansour; Marian A. Gerges ; Ayman M. Marei; Hanaa I. Abd El-Hady 
| ||||
| Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University | ||||
| Abstract | ||||
| Background: Warts constitute the commonest cutaneous manifestation of human papillomavirus (HPV) infection. Intralesional Candida antigen immunotherapy is used for wart treatment especially with resistant cases. Objective: To detect the association between different HPV genotypes, level of induced protein 10 (IP-10) and the clinical response to Candida antigen immunotherapy. Methodology: A cross-section study was conducted on 57 patients with resistant warts. All patients were injected with Candida antigen intralesionally at 2-weeks intervals for six treatment sessions. Clinical response was evaluated after 6 sessions. HPV genotyping was performed using real time PCR. Whole blood from patients was incubated with Candida antigen and IP-10 level was measured by ELISA. Results: Among the 57 injected patients, 31 (54.4%), 18 (31.6%), 8 (14%) show complete, partial and no response respectively. The most frequently detected genotype was HPV-39 (7.1 %) from HPV positive samples. Viral genotype had no significant relation (P=0.305) with patients’ clinical response. Statistically significant different IP-10 levels (P<0.001) were detected with different clinical responses. In conclusion: HPV genotype has no significant relation with the clinical response to Candida antigen immunotherapy in wart patients. IP-10 level is an excellent predictive factor for the immune response and hence for the clinical response in those patients. | ||||
| Keywords | ||||
| HPV; Wart; IP-10; Candida antigen | ||||
|
Statistics Article View: 49 PDF Download: 40 |
||||
